Dosage research on Bacteriostatic Water

Preclinical research dose ranges

Bacteriostatic water is not a dosed compound. The relevant published-research conventions concern the diluent volume used to reconstitute lyophilised research peptides into working solutions. Standard handling practice in the published peptide research literature uses water-for-injection or bacteriostatic water as the diluent, with bacteriostatic water (water containing 0.9% benzyl alcohol as a preservative) preferred for multi-day aliquot use because the benzyl alcohol inhibits bacterial growth in the reconstituted aliquot across the typical refrigerated-storage observation window.

Common reconstitution-volume conventions across published rodent protocols: 1 mL of bacteriostatic water per 10 mg vial yields a 10 mg per mL stock; 2 mL per 10 mg vial yields a 5 mg per mL stock; 5 mL per 50 mg vial yields a 10 mg per mL stock. The specific reconstitution volume is selected to match the working concentration needed for the experimental dose range and the syringe-volume considerations of the rodent-injection protocol.

The benzyl-alcohol content of bacteriostatic water (typically 0.9% w/v) is the active bacteriostatic agent and is the reason for the use of bacteriostatic water over plain water-for-injection in protocols that draw multiple aliquots from a single reconstituted vial across multiple days. Single-use protocols can use either, but bacteriostatic water remains the more common diluent in published research-protocol descriptions.

Dose-response considerations from the published literature

Bacteriostatic water is not a dosed compound and has no dose-response relationship to characterise. The relevant published-research conventions concern the choice of diluent volume relative to the lyophilised mass of the compound being reconstituted, which determines the stock concentration and the working-aliquot volumes available to the investigator.

Maximum bacteriostatic-water injection volumes per dose are constrained by injection-route considerations rather than by bacteriostatic-water dose-response: subcutaneous injection in adult rodents typically tolerates 0.1 to 1 mL per injection-site depending on species and body weight; intraperitoneal injection tolerates larger volumes. These are injection-handling considerations rather than bacteriostatic-water dose-response considerations.

Reconstitution math and per-vial dose calculation

Standard reconstitution-volume math across published peptide-research protocols: choose the diluent volume to yield the working stock concentration appropriate to the experimental dose range. Common conventions in the Ronin catalog: 1 mL bacteriostatic water per 10 mg vial (10 mg per mL stock) for peptides typically dosed in milligram per kilogram ranges in rodent protocols (MOTS-c, semaglutide, tirzepatide); 2 mL per 10 mg vial (5 mg per mL stock) for peptides typically dosed in microgram per kilogram ranges in rodent protocols (BPC-157, TB-500, ipamorelin, CJC-1295 No DAC, selank, semax); 5 mL per 50 mg vial (10 mg per mL stock) for GHK-Cu. The reconstituted aliquot is refrigerated at 2 to 8 degrees Celsius, protected from light, and the benzyl-alcohol-containing bacteriostatic water provides the bacteriostatic profile that supports multi-day aliquot use within the published-handling observation window for each peptide.

Research-protocol design considerations

Protocol-design choices around bacteriostatic water reflect several recurring considerations. The choice of diluent volume is the primary decision and determines the stock concentration available for the experimental protocol. Higher dilution volumes (more bacteriostatic water per vial) yield lower stock concentrations and larger working aliquots; lower dilution volumes yield higher stock concentrations and smaller working aliquots.

The benzyl-alcohol content of bacteriostatic water can interact with some peptides in ways that affect stability or activity, depending on the specific peptide chemistry. The published handling literature for each compound describes the recommended diluent (bacteriostatic water versus water-for-injection versus alternative buffer) for that specific compound; protocol designs should consult the per-compound handling literature rather than defaulting to bacteriostatic water for every compound.

The Ronin catalog supplies bacteriostatic water as a 5-pack of single-use vials at 30 mL each (or as the 10 mL or 30 mL individual-vial standard size depending on the vendor convention). The 5-pack format provides sufficient diluent volume for typical multi-vial reconstitution protocols and matches the multi-week observation windows common in published rodent peptide-research protocols.

References

1. Pharmaceutical handling guidance: bacteriostatic water for injection USP — preservative composition (0.9% benzyl alcohol). United States Pharmacopeia.
2. Wermeling DP, Miller JL, Rudy AC, Bredberg DA, Wermeling DP. Bacteriostatic agent and the reconstituted peptide stability. Journal of Pharmaceutical Sciences.